Wutah pendapatan triwulanan: Exact Sciences Corporation (EXAS)

Simbol lan logo merek Exact Sciences Corporation (EXAS)

Exact Sciences aims for global leadership in early cancer diagnostics through the implementation of non-invasive tests. Quarterly revenue growth percentages illustrate the link between this strategy and the capacity of its own sterile laboratories, where the indicator stood at 23.30. Positive sales momentum for Cologuard is currently supporting the share price, while future upside is embedded in the launch of next-generation liquid biopsies.

Exact Sciences Inc. (EXAS) - Owah-owahan dodolan kuartal marang kuartal saka 04.07.2022 nganti 04.04.2026

Rincian metrik lan analitis perusahaan Exact Sciences Corporation (EXAS)

Analisis wiwitan perusahaan:exactsciences.com (EXAS)
Produk seri exactsciences.com

Quarterly revenue growth measures the rate of increase in operating income, allowing for an assessment of business scaling intensity relative to the previous period. This metric serves as an indicator of market expansion and the fundamental stability of the issuer. By analyzing the dynamics of the quarterly revenue growth rate, an investor can discern the speed of product monetization. For Exact Sciences (EXAS), this confirms stable demand for Cologuard tests, which are established in medical protocols.

Pesaing Exact Sciences

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Wutah dodolan triwulanan|RVTY (Revvity) - Wutah pendapatan kuartal marang kuartal|BIO (Bio-Rad Laboratories, Inc.) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Anbio Biotechnology NNNN|Wutah dodolan triwulanan SHC (Sotera Health Company)|Wutah pendapatan kuartal marang kuartal QDEL (quidel.com)|Wutah pendapatan triwulanan OPK (opko.com)|Tambahing pendapatan triwulanan CDNA|MRVI: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan FLGT (Fulgent Corp)|LAB: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal cytekbio.com (CTKB)|OSUR (OraSure Corp) - Wutah pendapatan triwulanan|Exagen (XGN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Prenetics PRE|Insight Molecular (IMDX) - Tingkat wutah pendapatan sajrone kuartal|Trinity Biotech Corp - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal ProPhase PRPH|AIMD: Wutah pendapatan triwulanan|CODX - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Heart Test Laboratories, Inc.|Wutah pendapatan kuartal marang kuartal BMRA|Wutah pendapatan triwulanan CDIO|Onconetix - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal viraxbiolabs.com VRAX|Tingkat wutah dodolan sajrone kuartal Bluejay (BJDX)|AWH: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ENZ (Enzo)|Wutah dodolan kuartal marang kuartal Fresh2 (FRES)|Genetic Technologies (GENE) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ME|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)